AI Summary
We reviewed 19 live results for xeljanz (tofacitinib) and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Pharmaceutical and Extended Release Tablets.
Comparison Table
Recommended
XELJANZ XR
Source: Pfizer (Thailand) Ltd.
Description
XELJANZ XR is the extended-release formulation of tofacitinib, delivered in 11 mg tablets for once-daily dosing. It is indicated for the treatment of inflammatory conditions like rheumatoid arthritis and psoriatic arthritis where consistent medicine levels are required.
Best for
once-daily dosing, long-term maintenance and chronic inflammation management
View Details
Rating
XELJANZ
Source: Pfizer (Thailand) Ltd.
Description
XELJANZ is a prescription medicine containing tofacitinib, a Janus kinase (JAK) inhibitor used to treat adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It is available as 5 mg film-coated tablets and is registered with the Thai FDA.
Best for
rheumatoid arthritis patients, psoriatic arthritis, hospital prescriptions and official brand preference
View Details
Rating
Xeljanz (Tofacitinib)
Source: Pfizer Thailand
Description
Xeljanz is the innovator brand of tofacitinib registered in Thailand. It is available in 5 mg film-coated tablets and 11 mg extended-release (XR) formats for the treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis at major hospitals.
Best for
patients in Thailand, innovator drug preference, insured medical treatments and hospital-based pharmacy users
View Details
Rating
| Compare | XELJANZ XR | XELJANZ | Xeljanz (Tofacitinib) |
|---|---|---|---|
| Source | Pfizer (Thailand) Ltd. | Pfizer (Thailand) Ltd. | Pfizer Thailand |
| Description | XELJANZ XR is the extended-release formulation of tofacitinib, delivered in 11 mg tablets for once-daily dosing. It is indicated for the treatment of inflammatory conditions like rheumatoid arthritis and psoriatic arthritis where consistent medicine levels are required. | XELJANZ is a prescription medicine containing tofacitinib, a Janus kinase (JAK) inhibitor used to treat adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It is available as 5 mg film-coated tablets and is registered with the Thai FDA. | Xeljanz is the innovator brand of tofacitinib registered in Thailand. It is available in 5 mg film-coated tablets and 11 mg extended-release (XR) formats for the treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis at major hospitals. |
| Best for | once-daily dosing, long-term maintenance and chronic inflammation management | rheumatoid arthritis patients, psoriatic arthritis, hospital prescriptions and official brand preference | patients in Thailand, innovator drug preference, insured medical treatments and hospital-based pharmacy users |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
AI Recommendation
If you want the most balanced option to start with, I recommend:
"XELJANZ XR from Pfizer (Thailand) Ltd.."
I picked this because Offers the convenience of once-daily dosing through its extended-release formulation, supported by Pfizer's official clinical standards.
Share this search
Related Finds